Reactive aldehyde modification of thioredoxin-1 activates early steps of inflammation and cell adhesion

American Journal of Pathology

Volumn 171, Issue 5, 2007, Pages 1670-1681

  Go, Young Mi ^a   Halvey, Patrick J ^a   Hansen, Jason M ^a   Reed, Matt ^b   Pohl, Jan ^b   Jones, Dean P ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; ACROLEIN; ALDEHYDE DERIVATIVE; CD31 ANTIGEN; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; PROTEIN C JUN; REACTIVE OXYGEN METABOLITE; THIOREDOXIN;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CELL ADHESION; CHEMICAL MODIFICATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME PHOSPHORYLATION; IN VITRO STUDY; LIPID PEROXIDATION; MASS SPECTROMETRY; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING;

EID: 36348954964     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.070218     Document Type: Article

References (35)

1. Takagi Y, Gon Y, Todaka T, Nozaki K, Nishiyama A, Sono H, Hashimoto N, Kikuchi H, Yodoi J: Expression of thioredoxin is enhanced in atherosclerotic plaques and during neointima formation in rat arteries. Lab Invest 1998, 78:957-966
2. Yamawaki H, Haendeler J, Berk BC: Thioredoxin: a key regulator of cardiovascular homeostasis. Circ Res 2003, 93:1029-1033
3. Casagrande S, Bonetto V, Fratelli M, Gianazza E, Eberini I, Massignan T, Salmona M, Chang G, Holmgren A, Ghezzi P: Glutathionylation of human thioredoxin: a possible crosstalk between the glutathione and thioredoxin systems. Proc Natl Acad Sci USA 2002, 99:9745-9749
4. Haendeler J, Hoffmann J, Tischler V, Berk BC, Zeiher AM, Dimmeler S: Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69. Nat Cell Biol 2002, 4:743-749
5. Watson WH, Pohl J, Montfort WR, Stuchlik O, Reed MS, Powis G, Jones DP: Redox potential of human thioredoxin 1 and identification of a second dithiol/disulfide motif. J Biol Chem 2003, 278:33408-33415
6. Ishii T, Itoh K, Ruiz E, Leake DS, Unoki H, Yamamoto M, Mann GE: Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal. Circ Res 2004, 94:609-616
7. Landar A, Zmijewski JW, Dickinson DA, Le Goffe C, Johnson MS, Milne GL, Zanoni G, Vidari G, Morrow JD, Darley-Usmar VM: Interaction of electrophilic lipid oxidation products with mitochondria in endothelial cells and formation of reactive oxygen species. Am J Physiol Heart Circ Physiol 2006, 290:H1777-H1787
8. Chen ZH, Saito Y, Yoshida Y, Sekine A, Noguchi N, Niki E: 4-Hydroxynonenal induces adaptive response and enhances PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via activation of Nrf2. J Biol Chem 2005, 280:41921-41927
9. Yang X, Wu X, Choi YE, Kern JC, Kehrer JP: Effect of acrolein and glutathione depleting agents on thioredoxin. Toxicology 2004, 204:209-218
10. Fang J, Holmgren A: Inhibition of thioredoxin and thioredoxin reductase by 4-hydroxy-2-nonenal in vitro and in vivo. J Am Chem Soc 2006, 128:1879-1885
11. Kurtz AJ, Lloyd RS: 1,N2-Deoxyguanosine adducts of acrolein, crotonaldehyde, and trans-4-hydroxynonenal cross-link to peptides via Schiff base linkage. J Biol Chem 2003, 278:5970-5976
12. Sayre LM, Lin D, Yuan Q, Zhu X, Tang X: Protein adducts generated from products of lipid oxidation: focus on HNE and one. Drug Metab Rev 2006, 38:651-675
13. Halvey PJ, Watson WH, Hansen JM, Go YM, Samali A, Jones DP: Compartmental oxidation of thiol-disulphide redox couples during epidermal growth factor signaling. Biochem J 2005, 386:215-219
14. Go YM, Jones DP: Intracellular proatherogenic events and cell adhesion modulated by extracellular thiol/disulfide redox state. Circulation 2005, 111:2973-2980
15. Sasada T, Nakamura H, Ueda S, Sato N, Kitaoka Y, Gon Y, Takabayashi A, Spyrou G, Holmgren A, Yodoi J: Possible involvement of thioredoxin reductase as well as thioredoxin in cellular sensitivity to cis-diamminedichloroplatinum (II). Free Radic Biol Med 1999, 27:504-514
16. Jones DP: Redox potential of GSH/GSSG couple: assay and biological significance. Methods Enzymol 2002, 348:93-112
17. Rahman I, Li XY, Donaldson K, Macnee W: Cigarette smoke, glutathione metabolism and epithelial permeability in rat lungs. Biochem Soc Trans 1995, 23:235S
18. Uchida K: Current status of acrolein as a lipid peroxidation product. Trends Cardiovasc Med 1999, 9:109-113
19. Usatyuk PV, Parinandi NL, Natarajan V: Redox regulation of 4-hydroxy-2-nonenal-mediated endothelial barrier dysfunction by focal adhesion, adherens, and tight junction proteins. J Biol Chem 2006, 281:35554-35566
20. Ranganna K, Yousefipour Z, Nasif R, Yatsu FM, Milton SG, Hayes BE: Acrolein activates mitogen-activated protein kinase signal transduction pathways in rat vascular smooth muscle cells. Mol Cell Biochem 2002, 240:83-98
21. Haendeler J, Hoffmann J, Zeiher AM, Dimmeler S: Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins. Circulation 2004, 110:856-861
22. Tao L, Gao E, Bryan NS, Qu Y, Liu HR, Hu A, Christopher TA, Lopez BL, Yodoi J, Koch WJ, Feelisch M, Ma XL: Cardioprotective effects of thioredoxin in myocardial ischemia and reperfusion: role of S-nitrosation [corrected]. Proc Natl Acad Sci USA 2004, 101:11471-11476
23. Tao L, Jiao X, Gao E, Lau WB, Yuan Y, Lopez B, Christopher T, RamachandraRao SP, Williams W, Southan G, Sharma K, Koch W, Ma XL: Nitrative inactivation of thioredoxin-1 and its role in postischemic myocardial apoptosis. Circulation 2006, 114:1395-1402
24. Sakata K, Kashiwagi K, Sharmin S, Ueda S, Irie Y, Murotani N, Igarashi K: Increase in putrescine, amine oxidase, and acrolein in plasma of renal failure patients. Biochem Biophys Res Commun 2003, 305:143-149
25. Kehrer JP, Biswal SS: The molecular effects of acrolein. Toxicol Sci 2000, 57:6-15
26. Uchida K, Kanematsu M, Sakai K, Matsuda T, Hattori N, Mizuno Y, Suzuki D, Miyata T, Noguchi N, Niki E, Osawa T: Protein-bound acrolein: potential markers for oxidative stress. Proc Natl Acad Sci USA 1998, 95:4882-4887
27. Gil L, Siems W, Mazurek B, Gross J, Schroeder P, Voss P, Grune T: Age-associated analysis of oxidative stress parameters in human plasma and erythrocytes. Free Radic Res 2006, 40:495-505
28. Zamara E, Novo E, Marra F, Gentilini A, Romanelli RG, Caligiuri A, Robino G, Tamagno E, Aragno M, Danni O, Autelli R, Colombatto S, Dianzani MU, Pinzani M, Parola M: 4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells. J Hepatol 2004, 40:60-68
29. Kallis GB, Holmgren A: Differential reactivity of the functional sulfhydryl groups of cysteine-32 and cysteine-35 present in the reduced form of thioredoxin from Escherichia coli. J Biol Chem 1980, 255:10261-10265
30. Jordan BF, Runquist M, Raghunand N, Gillies RJ, Tate WR, Powis G, Baker AF: The thioredoxin-1 inhibitor 1-methylpropyl 2-imidazolyl disulfide (PX-12) decreases vascular permeability in tumor xenografts monitored by dynamic contrast enhanced magnetic resonance imaging. Clin Cancer Res 2005, 11:529-536
31. Kirkpatrick DL, Kuperus M, Dowdeswell M, Potier N, Donald LJ, Kunkel M, Berggren M, Angulo M, Powis G: Mechanisms of inhibition of the thioredoxin growth factor system by antitumor 2-imidazolyl disulfides. Biochem Pharmacol 1998, 55:987-994
32. Weichsel A, Gasdaska JR, Powis G, Montfort WR: Crystal structures of reduced, oxidized, and mutated human thioredoxins: evidence for a regulatory homodimer. Structure 1996, 4:735-751
33. Smeets A, Evrard C, Landtmeters M, Marchand C, Knoops B, Declercq JP: Crystal structures of oxidized and reduced forms of human mitochondrial thioredoxin 2. Protein Sci 2005, 14:2610-2621
34. Park YS, Misonou Y, Fujiwara N, Takahashi M, Miyamoto Y, Koh YH, Suzuki K, Taniguchi N: Induction of thioredoxin reductase as an adaptive response to acrolein in human umbilical vein endothelial cells. Biochem Biophys Res Commun 2005, 327:1058-1065
35. Biswal S, Acquaah-Mensah G, Datta K, Wu X, Kehrer JP: Inhibition of cell proliferation and AP-1 activity by acrolein in human A549 lung adenocarcinoma cells due to thiol imbalance and covalent modifications. Chem Res Toxicol 2002, 15:180-186